Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography
about
The development, past achievements, and future directions of brain PETMolecular imaging biomarkers for dementia with Lewy bodies: an update.PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.An update on brain imaging in parkinsonian dementiaAmyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia.Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classificationsC9ORF72 expansion in a family with bipolar disorderAppropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationAssessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging.Imaging the role of amyloid in PD dementia and dementia with Lewy bodies.Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes.Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.Extremely Low Prevalence of Amyloid Positron Emission Tomography Positivity in Parkinson's Disease without Dementia.
P2860
Q27026331-134730F8-86FC-4EAC-A55D-EA3FBEAF9A2BQ30881333-6A2332FF-1CD7-4EA7-91ED-CFAEB220A7D4Q33637285-4843FD47-DEAA-45B8-A729-A672E582CDDCQ34327937-57C09B18-720E-4BCC-8C53-8AC21DB367B5Q35603195-D2B500E1-EE25-4B16-BF2E-5F8E266351A1Q35840614-62CF9E10-EA99-4768-A2C7-A91D48E7D709Q36397544-45470310-C463-4E6A-A6D5-A7D03B6E9849Q36475260-18432B66-9585-4DD8-9D8C-731295B61CBFQ36813196-08781177-7A50-434A-9218-E1D2778E26D1Q36864788-2A386F84-49BB-4F28-8E01-19981D9B13A3Q37069527-D7503243-51B5-472B-8C4D-A0491BD6E437Q37214791-85ED48A2-1FDE-4B77-AEF5-6536652BA406Q38228098-BF33B46A-99C0-4581-8C9B-416DE47F32B8Q38368611-501228DE-39BF-4399-A3F7-5EB0A9383B4CQ38642389-85BE2CEA-F417-4AC6-8358-FA161B5D0228Q48267581-BE861148-5083-43A6-86A6-A859FB96E8C1
P2860
Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Assessment of mild dementia wi ...... l positron emission tomography
@ast
Assessment of mild dementia wi ...... l positron emission tomography
@en
type
label
Assessment of mild dementia wi ...... l positron emission tomography
@ast
Assessment of mild dementia wi ...... l positron emission tomography
@en
prefLabel
Assessment of mild dementia wi ...... l positron emission tomography
@ast
Assessment of mild dementia wi ...... l positron emission tomography
@en
P2093
P2860
P356
P1433
P1476
Assessment of mild dementia wi ...... l positron emission tomography
@en
P2093
Bruno Giordani
James F Burke
Kirk A Frey
Michael R Kilbourn
Robert A Koeppe
Roger L Albin
Sid Gilman
P2860
P304
P356
10.1093/BRAIN/AWR089
P407
P577
2011-05-09T00:00:00Z